SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a 50-Year-Old antipsychotic drug shrink Hard-to-Treat cancers?
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with small cell lung or cervical cancer that has returned after at least two prior treatments. The goal is to see if the drug can shrink tumors or slow disease progression. Participants take the …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Promising new cocktail takes on tough lung cancer
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer who have not had treatment before. The approach combines the drug bemotuzumab with standard chemotherapy and another drug called anlotinib, followed by chest radiation. The goal is to see if t…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Engineered immune cells take on tough cancers in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called ML261 for people with small cell lung cancer or certain neuroendocrine cancers that have come back or not responded to standard therapy. ML261 uses a patient's own immune cells, which are modified in a lab to better recognize an…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New drug combo aims to tame tough lung cancer
Disease control Not yet recruitingThis study tests a new drug combination (alisertib plus paclitaxel) in people with small cell lung cancer who have already tried other treatments. The main goal is to find safe doses and see what side effects occur. About 50 adults will take alisertib pills and receive paclitaxel…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC